AstraZeneca’s mantle cell cancer drug gets body’s nod for EU approval
HQ Team April 1, 2025: AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union
HQ Team April 1, 2025: AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union
HQ Team April 1, 2025: One to five years of antidepressant usage, increases the risk of sudden cardiac death by 56%, according to
HQ Team March 26, 2025: The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in
HQ Team March 26, 2025: The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that
HQ Team Wednesday 26, 2025: At least 2,515 people were killed along the perilous migration routes in Asia last year, making it the
HQ Team March 25, 2025: Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from
HQ Team March 25, 2025: A diet rich in plant-based foods during midlife, with a lower intake of ultra-processed and moderate animal-based foods
HQ Team February 25, 2025: Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and
HQ Team March 25, 2025: Progress in slowing child mortality and stillbirth deaths has received a severe blow due to global funding cuts